146 related articles for article (PubMed ID: 38141835)
1. Polypharmacy and potential drug-drug interactions among people living with HIV in the era of integrase strand transfer inhibitor-based antiretroviral therapy.
Peng AT; Huang SH; Lee HY; Wu PY; Kuo HY; Hung CC
Int J Antimicrob Agents; 2024 Feb; 63(2):107067. PubMed ID: 38141835
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Polypharmacy and Potential Drug-Drug Interactions Associated with Risk Factors in the Era of HIV Integrase Inhibitors: A Prospective Clinical Study.
Altunal LN; Yagcı Caglayık D; Ozel AS; Tukenmez Tigen E; Sili U; Erturk Sengel B; Aydın M; Korten V
AIDS Patient Care STDS; 2023 Mar; 37(3):138-145. PubMed ID: 36812461
[TBL] [Abstract][Full Text] [Related]
3. Use of comedications and potential drug-drug interactions in people living with HIV in China.
Chen R; Chen J; Tang Q; Meng Z; Luo L; Zhang W; Deng A; Zhang L; Wang J; Qi T; Zhang R; Shen Y; Liu L; Steinhart C; Lu H
J Infect Chemother; 2020 Jul; 26(7):722-728. PubMed ID: 32354599
[TBL] [Abstract][Full Text] [Related]
4. Co-medications and Drug-Drug Interactions in People Living with HIV in Turkey in the Era of Integrase Inhibitors.
Yeşilbağ Z; Şengül Eİ; Şenoğlu S; Aydın ÖA; Karaosmanoğlu HK
Curr HIV Res; 2020; 18(6):415-425. PubMed ID: 32787762
[TBL] [Abstract][Full Text] [Related]
5. Polypharmacy and Drug-Drug Interactions in People Living With Human Immunodeficiency Virus in the Region of Madrid, Spain: A Population-Based Study.
López-Centeno B; Badenes-Olmedo C; Mataix-Sanjuan Á; McAllister K; Bellón JM; Gibbons S; Balsalobre P; Pérez-Latorre L; Benedí J; Marzolini C; Aranguren-Oyarzábal A; Khoo S; Calvo-Alcántara MJ; Berenguer J
Clin Infect Dis; 2020 Jul; 71(2):353-362. PubMed ID: 31428770
[TBL] [Abstract][Full Text] [Related]
6. Comedication prescription patterns and potential for drug-drug interactions with antiretroviral therapy in people living with human immunodeficiency virus type 1 infection in Germany.
Lopes S; O'Day K; Meyer K; Van Stiphout J; Punekar Y; Radford M; Haas JS
Pharmacoepidemiol Drug Saf; 2020 Mar; 29(3):270-278. PubMed ID: 31950545
[TBL] [Abstract][Full Text] [Related]
7. The Challenge of Potential Drug-Drug Interactions Among People Living With HIV on Antiretroviral Therapy: A Cross-Sectional Study in Selected Provinces in China.
Xia H; Gao L; Gong X; Zaongo SD; Zhang T; Wu H; Ma P; Huang X
Front Pharmacol; 2020; 11():800. PubMed ID: 32536872
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with incomplete adherence to integrase strand transfer inhibitor-containing single-tablet regimen among Japanese people living with HIV.
Kunimoto Y; Hikasa S; Ishihara M; Tsukiji M; Nobori K; Kimura T; Onishi K; Yamamoto Y; Haruta K; Kasiwabara Y; Fujii K; Fukudo M
J Pharm Health Care Sci; 2024 Jun; 10(1):27. PubMed ID: 38840139
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with polypharmacy and the prescription of multiple medications among persons living with HIV (PLWH) compared to non-PLWH.
Moore HN; Mao L; Oramasionwu CU
AIDS Care; 2015; 27(12):1443-8. PubMed ID: 26608408
[TBL] [Abstract][Full Text] [Related]
10. CD4/CD8 Ratio Recovery Among People Living With HIV Starting With First-Line Integrase Strand Transfer Inhibitors: A Prospective Regional Cohort Analysis.
Han WM; Avihingsanon A; Rajasuriar R; Tanuma J; Mundhe S; Lee MP; Choi JY; Pujari S; Chan YJ; Somia A; Zhang F; Kumarasamy N; Tek Ng O; Gani Y; Chaiwarith R; Pham TN; Do CD; Ditangco R; Kiertiburanakul S; Khol V; Ross J; Jiamsakul A;
J Acquir Immune Defic Syndr; 2023 Feb; 92(2):180-188. PubMed ID: 36625858
[TBL] [Abstract][Full Text] [Related]
11. Relationship of polypharmacy to HIV RNA suppression in people aged ≥ 50 years living with HIV.
Murray MM; Lin J; Buros Stein A; Wilcox ML; Cottreau J; Postelnick M; Palella FJ
HIV Med; 2021 Sep; 22(8):742-749. PubMed ID: 34077632
[TBL] [Abstract][Full Text] [Related]
12. Weight gain after antiretroviral therapy initiation in people living with HIV in the United States: analyses of electronic medical records and prescription claims.
Zhao X; Prajapati G; Tse J; Near AM; Kumar PN
Curr Med Res Opin; 2023 Jul; 39(7):997-1006. PubMed ID: 37334707
[TBL] [Abstract][Full Text] [Related]
13. Recognition of possible risk factors for clinically significant drug-drug interactions among Indian people living with HIV receiving highly active antiretroviral therapy and concomitant medications.
Priyanka PSSL; Varma DM; Immadisetti K; Rajesh R; Vidyasagar S; Guddattu V
Int J Risk Saf Med; 2017; 29(1-2):25-55. PubMed ID: 28885219
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of drug-drug interactions in the era of HIV integrase inhibitors: a retrospective clinical study.
Baecke C; Gyssens IC; Decoutere L; van der Hilst JCH; Messiaen P
Neth J Med; 2017 Jul; 75(6):235-240. PubMed ID: 28741582
[TBL] [Abstract][Full Text] [Related]
15. Incidence of cardiometabolic outcomes among people living with HIV-1 initiated on integrase strand transfer inhibitor versus non-integrase strand transfer inhibitor antiretroviral therapies: a retrospective analysis of insurance claims in the United States.
Rebeiro PF; Emond B; Rossi C; Bookhart BK; Shah A; Caron-Lapointe G; Lafeuille MH; Donga P
J Int AIDS Soc; 2023 Jun; 26(6):e26123. PubMed ID: 37306118
[TBL] [Abstract][Full Text] [Related]
16. Polypharmacy and potential drug-drug interactions for people with HIV in the UK from the Climate-HIV database.
Okoli C; Schwenk A; Radford M; Myland M; Taylor S; Darley A; Barnes J; Fox A; Grimson F; Reeves I; Munshi S; Croucher A; Boxall N; Benn P; Paice A; van Wyk J; Khoo S
HIV Med; 2020 Sep; 21(8):471-480. PubMed ID: 32671950
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Potential Drug-Drug Interactions in Patients of the Swiss HIV Cohort Study in the Era of HIV Integrase Inhibitors.
Deutschmann E; Bucher HC; Jaeckel S; Gibbons S; McAllister K; Scherrer AU; Braun DL; Cavassini M; Hachfeld A; Calmy A; Battegay M; Cipriani M; Elzi L; Young J; Lopez-Centeno B; Berenguer J; Khoo S; Moffa G; Marzolini C;
Clin Infect Dis; 2021 Oct; 73(7):e2145-e2152. PubMed ID: 32634832
[TBL] [Abstract][Full Text] [Related]
18. Non-HIV Comorbid Conditions and Polypharmacy Among People Living with HIV Age 65 or Older Compared with HIV-Negative Individuals Age 65 or Older in the United States: A Retrospective Claims-Based Analysis.
Kong AM; Pozen A; Anastos K; Kelvin EA; Nash D
AIDS Patient Care STDS; 2019 Mar; 33(3):93-103. PubMed ID: 30844304
[TBL] [Abstract][Full Text] [Related]
19. Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort Collaboration.
Rein SM; Lodi S; Logan RW; Touloumi G; Antoniadou A; Wittkop L; Bonnet F; van Sighem A; van der Valk M; Reiss P; Klein MB; Young J; Jarrin I; d'Arminio Monforte A; Tavelli A; Meyer L; Tran L; Gill MJ; Lang R; Surial B; Haas AD; Justice AC; Rentsch CT; Phillips A; Sabin CA; Miro JM; Trickey A; Ingle SM; Sterne JAC; Hernán MA;
Lancet HIV; 2023 Nov; 10(11):e723-e732. PubMed ID: 37923486
[TBL] [Abstract][Full Text] [Related]
20. Potential or contraindicated drug-drug interactions with antiretroviral therapy in real-world settings in Taiwan.
Wang CC; Li HJ; Shao CH; Sheng WH
J Formos Med Assoc; 2022 Sep; 121(9):1714-1720. PubMed ID: 34961668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
